20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Global Market for Cancer Drug Raw Materials: Focus on Docetaxel

The global market for cancer drug raw materials is a dynamic and critical sector, driven by the ongoing need for effective oncology treatments. Within this landscape, Docetaxel, identified by CAS 114977-28-5, plays a pivotal role. As a key pharmaceutical intermediate, its demand is closely tied to the prevalence of cancers such as breast, lung, prostate, and gastric cancers, for which it is a primary therapeutic agent. NINGBO INNO PHARMCHEM CO., LTD. actively participates in this market, supplying high-purity Docetaxel pharmaceutical intermediate to manufacturers worldwide.

The steady increase in cancer diagnoses globally fuels the demand for advanced chemotherapy drugs, consequently driving the market for essential components like Docetaxel API. Manufacturers seeking to buy Docetaxel raw material are looking for reliable partners who can consistently deliver pharmaceutical grade products. Our position in the market is built on our ability to meet these demands with a product that adheres to the highest quality standards, ensuring its suitability for complex pharmaceutical synthesis.

Understanding the intricacies of the cancer drug raw materials market involves recognizing the importance of supply chain stability and product integrity. The availability of high-quality Docetaxel pharmaceutical intermediate from trusted sources is crucial for ensuring that a consistent supply of cancer medications reaches patients. NINGBO INNO PHARMCHEM CO., LTD. is committed to being that trusted source, contributing to the global effort to combat cancer by providing essential chemical building blocks.

The economic and scientific significance of Docetaxel pharmaceutical intermediate within the broader pharmaceutical industry cannot be overstated. Its role in producing widely used and highly effective cancer treatments makes it a commodity of great importance. We are proud to be a supplier in this vital market, supporting the pharmaceutical sector's continuous efforts to develop and deliver innovative and life-saving cancer therapies. Partner with us for your Docetaxel needs and join a commitment to global health.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Ensuring Patient Safety: The Quality of Docetaxel API

Next: Innovating Cancer Therapies: The Role of Docetaxel in Drug Development

All Rights Reserved